Joining us today is Panna Sharma, Chief Executive Officer, President and Director of Lantern Pharma, who will guide us through the demonstration and discuss the broader implications of this technology ...
The company has a flexible approach that makes use of its antibody platform downstream process where appropriate, and augments its development process with high-throughput (HT) approaches to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results